Pinkus Tober‐Lau - Concepedia

Author

Pinkus Tober‐Lau

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Frank Tacke, P. Tober-Lau, Paula Stubbemann, Pinkus Tober-Lau, Pinkus Tober‐Lau

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Freie Universität Berlin Bernhard Nocht Institute for Tropical Medicine University Medical Center Hamburg-Eppendorf

About

Pinkus Tober‐Lau is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.1K
2	Public Health	2	2	161
3	Cell Biology	1	1	32
4	Clinical Immunology	1	1	73
5	Critical Care Medicine	1	1	62

Pinkus Tober‐Lau

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, Nature Medicine	2022	423
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau, The Lancet Respiratory Medicine VaccinationImmunodeficienciesImmunologyImmunologic MechanismImmunotherapeutics	2021	352
Complement activation induces excessive T cell cytotoxicity in severe COVID-19 Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, Cell	2021	216
A time-resolved proteomic and prognostic map of COVID-19 Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke, Cell Systems Accredited Diagnostic ParametersPrognosisImmunologySystemic Inflammatory ResponseTime-resolved Proteomic	2021	212
Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI Tariq U. Azam, Husam Shadid, Pennelope Blakely, Journal of the American Society of Nephrology	2020	127
A serum proteome signature to predict mortality in severe COVID-19 patients Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, Life Science Alliance ImmunodeficienciesPrognosisImmunologySevere Covid-19 PatientsPathology	2021	99
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany Tatjana Schwarz, Pinkus Tober‐Lau, David Hillus, Emerging infectious diseases	2021	85
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns Henning Gruell, Kanika Vanshylla, Michael Korenkov, Cell Host & Microbe ImmunologyVirologySars-cov-2 Omicron SublineagesAntibody EngineeringMedicine	2022	85
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau, Clinical ImmunologyImmunodeficienciesBoost ImmunisationImmunologyImmunodominance	2021	73
Monkeypox in-patients with severe anal pain Frieder Pfäfflin, Daniel Wendisch, Roland Scherer, Infection	2022	63

Page 1